Corrigendum to “Mild cognitive impairment due to Alzheimer disease: Contemporary approaches to diagnostics and pharmacological intervention” [Pharmacol. Res. 129 (2018) 216–226] (S1043661817309374) (10.1016/j.phrs.2017.11.021))
MetadataShow full item record
The authors regret that the text published was missing the following information:the e mail address of Dr S.O. Bachurin, a corresponding author, which is firstname.lastname@example.org; the affiliation of Dr G. Aliev is also *GALLY International Biomedical Research Consulting LLC, 7733 Louis Pasteur Drive, #330, San Antonio, TX, 78229, USA. The authors also state that they have no conflict of interest and that the research was supported in part by RSF project #14-23-00160P and the scientific projects of IPAC (topics 48.8. and 48.9). Authors’ also very grateful for the animal facilities were provided by Center for preclinical trials of IPAC RAS. The authors would like to apologise for any inconvenience caused. Conflict of interest The authors confirm that article content has no conflict of interest. © 2018 Elsevier Ltd
Showing items related by title, author, creator and subject.
Mild cognitive impairment due to Alzheimer disease: Contemporary approaches to diagnostics and pharmacological intervention (2020) Bachurin S.O.; Gavrilova S.I.; Samsonova A.; Barreto G.E.; Aliev G. (Academic Press, 2018)
Mitochondrial permeability transition pore as a suitable target for neuroprotective agents against alzheimer’s disease (2020) Shevtsova E.F.; Vinogradova D.V.; Neganova M.E.; Avila-Rodriguez M.; Ashraf G.M.; Barreto G.E.; Bachurin S.O.; Aliev G. (Bentham Science Publishers B.V., 2017)
ArticleNeganova M.E.; Klochkov S.G.; Petrova L.N.; Shevtsova E.F.; Afanasieva S.V.; Chudinova E.S.; Fisenko V.P.; Bachurin S.O.; Barreto G.E.; Aliev G. (Bentham Science Publishers B.V., 2017)